Comparison of distortion-product and transient evoked otoacoustic emissions with ABR threshold shift in chinchillas with ototoxic damage

Sex differences in the auditory functions of rodents

BACKGROUND

In humans, it is well known that females have better hearing than males. The mechanism of this influence of sex on auditory function in humans is not well understood. Testing the hypothesis of underlying mechanisms often relies on preclinical research, a field in which sex bias still exists unconsciously. Rodents are popular research models in hearing, thus it is crucial to understand the sex differences in these rodent models when studying health and disease in humans.

OBJECTIVES

This review aims to summarize the existing sex differences in the auditory functions of rodent species including mouse, rat, Guinea pig, Mongolian gerbil, and chinchilla. In addition, a concise summary of the hearing characteristics and the advantages and the drawbacks of conducting auditory experiments in each rodent species is provided.

DESIGNS

Manuscripts were identified in PubMed and Ovid Medline for the queries "Rodent", "Sex Characteristics", and "Hearing or Auditory Function". Manuscripts were included if they were original research, written in English, and use rodents. The content of each manuscript was screened for the sex of the rodents and the discussion of sex-based results.

CONCLUSIONS

The sex differences in auditory function of rodents are prevalent and influenced by multiple factors including physiological mechanisms, sex-based anatomical variations, and stimuli from the external environment. Such differences may play a role in understanding and explaining sex differences in hearing of humans and need to be taken into consideration for developing clinical therapies aim to improve auditory performances.

Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice

Aminoglycoside ototoxicity is common in clinical practice but reliable protective agents currently do not exist. Aminoglycoside regimens causing ototoxicity in different laboratory animals are under investigation. The assessment method used most commonly to determine auditory effects is the auditory brainstem response (ABR). Distortion product otoacoustic emissions (DPOAE) have been used less frequently. A precise recommendation on the specific method to assess peripheral auditory function before and after aminoglycoside toxicity in mice does not exist. In order to evaluate various mouse models for ototoxic injury caused by various aminoglycoside regimens, there is a need for performing preliminary tests in small cohorts before large experiments. The aim of our study was to investigate different aminoglycoside regimens that cause substantial ototoxic damage in vivo. Aminoglycosides are safe and produce a detectable hearing threshold shift in a small cohort of mice that can be used as a model for preliminary tests. Different ototoxic regimens were assessed by ABR and DPOAE measurements pre- and post-treatment. Further, the sensory cell loss was quantified by counting hair cells in the cochlea. It was revealed that an ototoxic regimen with kanamycin twice daily for 15 consecutive days is safe, well tolerated and produces an early significant hearing threshold shift detected by DPOAE in a small cohort of mice. The study compared ABR and DPOAE in mentioned regimens for the first time and illustrated that DPOAE is well suited for detecting hearing threshold shifts in high frequencies before ABR threshold shifts occur in accordance with predominating outer hair cell damage mainly in the basal turn of the cochlea.

Distortion product otoacoustic emission data in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents in the Pediatric HIV/AIDS Cohort Study

The effect of perinatal HIV infection and exposure on sub-clinical auditory function can be measured with distortion product otoacoustic emissions (DPOAEs). DPOAEs were obtained at 4 frequency bins (1, 2, 3 and 4 kHz) and categorized by a signal-to-noise ratio. HIV infection was not associated with poorer DPOAEs. Among HIV-infected children, HIV viral load≥400 copies/mL had significantly lower odds of better DPOAEs.

Local cochlear damage reduces local nonlinearity and decreases generator-type cochlear emissions while increasing reflector-type emissions

Distortion product otoacoustic emissions (DPOAEs) originate in cochlear nonlinearity and emerge into the ear canal as an apparent sum of emission types, one of which (generator) travels directly out and the other (reflector) travels out following linear reflection. The present study explores intracochlear sources of DPOAEs via simultaneous ear canal and intracochlear pressure measurements in gerbils. A locally damaged cochlea was produced with reduced local intracochlear nonlinearity and significant elevation of the compound action potential thresholds at frequencies represented within the damaged region. In the DPOAE the comparison of healthy to locally damaged cochleae showed the following: (1) In the broad frequency region corresponding to the locally damaged best frequency, DPOAEs evoked by wider f(2)/f(1) stimuli decreased, consistent with the reduction in local nonlinearity. (2) DPOAEs evoked by narrow f(2)/f(1) stimuli often had a bimodal change, decreasing in a lower frequency band and increasing in a band just adjacent and higher, and the DPOAE phase-vs-frequency slope steepened. These changes confirm the complex nature of the DPOAE.

Analysis of distortion product otoacoustic emission spectra in normal-hearing adults

PURPOSE

To evaluate the ability of distortion product otoacoustic emission (DPOAE) spectral characteristics to distinguish between ears with variable hearing sensitivity within the normal range.

METHOD

Distortion product grams (DP-grams) were acquired with primary tones decremented in 1/8-octave steps and primary-tone levels presented at 65 dB SPL (L1) and 45 dB SPL (L2) across an f2 frequency range of 842-7996 Hz from 22 normal-hearing adults (44 ears). Hearing thresholds of ears classified in Group A (n = 22) were better than ears classified in Group B (n = 22). Examined parameters of the DP-grams included spectral peak occurrence, peak height, peak width, and DPOAE levels. Analyses of variance were conducted to determine whether DP-gram parameters differed between Group A and Group B.

RESULTS

For the low-resolution DP-grams examined in this study, no significant between-group differences in peak occurrence, peak height, and peak width were observed. DPOAE levels were significantly higher in ears classified in Group A compared with ears classified in Group B in individuals with symmetrical hearing.

CONCLUSIONS

Although spectral peaks are evident in DP-grams acquired with low resolution of the primary tones, DPOAE levels are more effective in distinguishing ears with greater hearing sensitivity from less sensitive ears.

GATA3 haploinsufficiency causes a rapid deterioration of distortion product otoacoustic emissions (DPOAEs) in mice

Human HDR (hypoparathyroidism, deafness and renal dysplasia)-syndrome is caused by haploinsufficiency of zinc-finger transcription factor GATA3. The hearing loss due to GATA3 haploinsufficiency has been shown to be peripheral in origin, but it is unclear to what extent potential aberrations in the outer hair cells (OHCs) contribute to this disorder. To further elucidate the pathophysiological mechanism underlying the hearing defect in HDR-syndrome, we investigated the OHCs in heterozygous Gata3-knockout mice at both the functional and morphological level. While the signal-to-noise ratios of distortion product otoacoustic emissions (DPOAE) in wild type mice did not change significantly during the first half-year of live, those in the heterozygous Gata3 mice decreased dramatically. In addition, both light microscopic and transmission electron microscopic analyses showed that the number of OHCs containing vacuoles was increased in the mutants. Together, these findings indicate that outer hair cell malfunctioning plays a major role in the hearing loss in HDR-syndrome.

Transient-evoked stimulus-frequency and distortion-product otoacoustic emissions in normal and impaired ears

Transient-evoked stimulus-frequency otoacoustic emissions (SFOAEs), recorded using a nonlinear differential technique, and distortion-product otoacoustic emissions (DPOAEs) were measured in 17 normal-hearing and 10 hearing-impaired subjects using pairs of tone pips (pp), gated tones (gg), and for DPOAEs, continuous and gated tones (cg). Temporal envelopes of stimulus and OAE waveforms were obtained by narrow-band filtering at the stimulus or DP frequency. Mean SFOAE latencies in normal ears at 2.7 and 4.0 kHz decreased with increasing stimulus level and were larger at 4.0 kHz than latencies in impaired ears. Equivalent auditory filter bandwidths were calculated as a function of stimulus level from SFOAE latencies by assuming that cochlear transmission is minimum phase. DPOAE latencies varied less with level than SFOAE latencies. The ppDPOAEs often had two (or more) peaks separated in time with latencies consistent with model predictions for distortion and reflection components. Changes in ppDPOAE latency with level were sometimes explained by a shift in relative amplitudes of distortion and reflection components. The pp SFOAE SPL within the main spectral lobe of the pip stimulus was higher for normal ears in the higher-frequency half of the pip than the lower-frequency half, which is likely an effect of basilar membrane two-tone suppression.

Detecção precoce de ototoxicidade usando emissões otoacústicas produtivas de distorção

Introdução: Os aminoglicosídeos são potencialmente ototóxicos, sendo que a monitorização tradicional detecta ototoxicidade quando a lesão já aconteceu. Objetivo: Estudamos prospectivamente a audição de pacientes que recebiam amicacina, usando audiometria tonal liminar (ATL) e emissões otoacústicas, produtos de distorção (EOA-PD), visando a suspeita precoce de ototoxicidade e sua prevenção. Forma de estudo: Prospectivo randomizado. Material e método: Avaliamos, com ATL, 29 pacientes em tratamento com amicacina, para detectar alterações audiométricas. Desses 29 pacientes, três tiveram alteração na ATL em 6 e/ou 8 kHz (10,34 %) - um com alteração bilateral; os outros dois, unilateral (quatro ouvidos), todos assintomáticos. Realizamos EOA-PD, para estudar a função coclear. Dos 29 pacientes (58 ouvidos), nove (18 ouvidos) foram afastados do estudo por não completarem as testagens das EOA-PD, ficando 20 pacientes (40 ouvidos) para análise. Resultados: Não encontramos alterações significativas nas respostas das EOA-PD durante o vale e o pico sérico da amicacina, como esperado. Quando comparados os ouvidos com e sem alterações audiométricas, as variações das respostas não foram significativas em 1, 2 e 4 kHz; no entanto, em 6 e 8 kHz mostraram diferenças significativas (p<0,05). As respostas das EOA-PD nos ouvidos com ATL normal apresentaram incrementos mais do que quedas; e o contrário aconteceu nos ouvidos que apresentaram ATL alterada, ou seja: houve mais quedas do que incrementos. Conclusões: a ototoxicidade pode ser monitorada eficazmente com EOA-PD durante a administração da droga, independentemente do horário da sua administração; os incrementos nas respostas poderiam ser um sinal precoce de ototoxicidade por aminoglicosídeos.

Objective method for differentiating between drug-induced vestibulotoxicity and cochleotoxicity

HYPOTHESIS

An objective direct method is proposed to differentiate between drug-induced functional vestibulotoxicity and cochleotoxicity.

BACKGROUND

Many substances are ototoxic. Although there are objective methods to directly evaluate functional cochlear toxicity (auditory nerve brainstem responses [ABR]), it is more difficult to assess direct functional ototoxicity to the various vestibular end organs.

METHODS

Short-latency vestibular evoked potentials (VsEP) from different vestibular end organs and ABR, were used to assess functional impairment of the vestibular and cochlear end organs caused by daily injections of the aminoglycoside amikacin (known to be preferentially cochleotoxic) in guinea pigs.

RESULTS

There was no significant change in the various VsEPs. whereas ABR thresholds were elevated, confirming the selective functional cochleotoxicity previously reported, as evaluated by other (mainly nondirect) methods.

CONCLUSION

This study demonstrates the feasibility in general of using short-latency evoked potentials to evaluate functional cochleotoxicity and vestibulotoxicity of ototoxic drugs and to differentiate between them.